Search results
Viking Therapeutics Inc [VKTX] Shares Fall
Knox Daily· 2 days agoInvestors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Viking Therapeutics Inc
Where Will Viking Therapeutics Be in 5 Years?
Motley Fool via Yahoo Finance· 19 hours agoIf you're looking at up-and-coming healthcare stocks with significant potential in the anti-obesity market, one company you've likely come across is ...
Is It Too Late to Buy Viking Therapeutics Stock? | The Motley Fool
The Motley Fool· 4 days agoUp 260% so far this year, shares of Viking Therapeutics (VKTX -1.90%) are a hot commodity thanks to...
Weight-Loss Upstart Viking Needs a Deal to Vie With Lilly and Novo
Bloomberg via Yahoo Finance· 4 days ago(Bloomberg) -- Hope for a weight-loss drug that’s better than Ozempic and Wegovy has sent Viking ...
The Zacks Analyst Blog Highlights Stocks recently featured in the blog include: Novo Nordisk, Eli...
Zacks via Yahoo Finance· 6 days agoTherapeutics intends to meet with the FDA to discuss the above results to determine the next steps...
2 Stocks That Could 10x by 2035 | The Motley Fool
The Motley Fool· 2 days agoThere will be a slowdown, equities will fall, and many won't deliver anything approaching decent returns for years after. Viking Therapeutics is on a...
Viking Capital Announces Closing of Latest 268 Acquisition in Atlanta
Digital Journal· 6 days agoViking Capital and its investment opportunities, please visit www.vikingcapllc.com . Contact Information Ashley Penrod Director of Marketing apenrod@vikingcapllc.com 2088599720 ...
3 Biotech Stocks That Could Be Millionaire-Makers: May Edition
InvestorPlace· 15 hours agoAs we delve deeper into 2024, biotech stocks are commanding the attention of growth-focused...
EXCLUSIVE: Roundhill Investments Launches Weight Loss ETF For Exposure To Blockbuster Drugs Like...
Benzinga· 4 days agoRoundhill Investments launched a new exchange-traded fund (ETF) Tuesday. What Happened: The...
Where Will Novo Nordisk Be in 10 Years?
Motley Fool via Yahoo Finance· 18 hours agoWhile it may not chip away at Ozempic or Wegovy's market share today, it could be a formidable rival down the road. Viking Therapeutics' VK2735 is...
